Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Cardinal Health ( (CAH) ) has issued an announcement.
On September 30, 2025, Cardinal Health Funding, LLC, a subsidiary of Griffin Capital, and several financial institutions including Wells Fargo and Bank of America, entered into a First Amendment to extend the term of their receivables purchase agreement to September 28, 2028. This amendment aims to maintain the company’s financial flexibility and strengthen its position by ensuring continued access to financing, which is crucial for its operations and relationships with stakeholders.
The most recent analyst rating on (CAH) stock is a Hold with a $165.00 price target. To see the full list of analyst forecasts on Cardinal Health stock, see the CAH Stock Forecast page.
Spark’s Take on CAH Stock
According to Spark, TipRanks’ AI Analyst, CAH is a Neutral.
Cardinal Health’s overall stock score is driven by strong earnings growth and strategic acquisitions, which are expected to enhance future performance. However, significant financial leverage and cash flow management issues present risks. The technical indicators suggest a mild bullish trend, while the valuation appears relatively high, limiting upside potential.
To see Spark’s full report on CAH stock, click here.
More about Cardinal Health
Average Trading Volume: 2,293,620
Technical Sentiment Signal: Buy
Current Market Cap: $37.71B
Find detailed analytics on CAH stock on TipRanks’ Stock Analysis page.